Gives me the willies when I see the "buyout" word come around again. Think about it, 1 molecule! I think I've heard up to 40 or 50 viable indications maybe even more. CYDY's R&D would not be designing new drugs for new indications it would be 1 molecule only and with that 1 molecule only, what indications can we help people live with to make life easier or possibly cure. And with the BBB proof (WOW!) We would basically just be setting up trials and setting endpoints. Not having to prove safety because once we have a full approval our safety will have been proven. I think we would be making the other BP's and I say other BP's become more efficient and more focused because, at first we would be giving them a run for their money but eventually, they would be trying to catch us. Just Saying!